RADIOIMMUNOSCINTIGRAPHY WITH IN-111 LABELED MONOCLONAL-ANTIBODY FRAGMENTS (F(AB')2 BW 431/31) AGAINST CEA - RADIOLABELLING, ANTIBODY KINETICS AND DISTRIBUTION, FINDINGS IN TUMOR AND NON-TUMOR PATIENTS

被引：18
|
作者：
BARES, R
FASS, J
TRUONG, S
BUELL, U
SCHUMPELICK, V
机构：
来源：
NUCLEAR MEDICINE COMMUNICATIONS | 1989年 / 10卷 / 09期
关键词：
D O I：
10.1097/00006231-198909000-00002
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：627 / 641
页数：15
相关论文
共 45 条
  • [1] BIODISTRIBUTION AND PHARMACOKINETICS OF IN-111 LABELED MONOCLONAL-ANTIBODY F(AB')2 FRAGMENTS IN PATIENTS
    DOHERTY, PW
    BRITISH JOURNAL OF CANCER, 1985, 52 (04) : 646 - 647
  • [2] INTRAINDIVIDUAL COMPARISON OF SPECT-IMMUNOSCINTIGRAPHY AND PLANAR IMMUNOSCINTIGRAPHY WITH 111-IN-DTPA LABELED ANTI-CEA F(AB')2 MONOCLONAL-ANTIBODY FRAGMENTS (BW-431/31)
    FROHN, J
    BAUM, RP
    HAPP, J
    WEIMER, B
    HALBSGUTH, A
    LOCHNER, B
    HOR, G
    NUC COMPACT-EUROPEAN-AMERICAN COMMUNICATIONS IN NUCLEAR MEDICINE, 1989, 20 (05): : 161 - &
  • [3] EARLY IMMUNOSCINTIGRAPHIC LOCALIZATION OF A MEDIASTINAL TUMOR WITH INDIUM 111-DTPA CEA-SPECIFIC F(AB')2 MONOCLONAL-ANTIBODY FRAGMENTS (BW 431/31) USING 2ND TRACER ISOCONTOUR TECHNIQUE
    FROHN, J
    BAUM, RP
    HAPP, J
    FALK, S
    RIEMANN, HE
    HOR, G
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1990, 17 (1-2): : 91 - 93
  • [4] FACTORS AFFECTING IN-111 LABELED ANTI-CEA MONOCLONAL-ANTIBODY (INDACEA) BIODISTRIBUTION AND IMAGING - TUMOR CEA CONTENT AND TUMOR SIZE
    BEATTY, JD
    PHILBEN, VJ
    BEATTY, BG
    JAKOWATZ, JG
    VLAHOS, WG
    WILLIAMS, LE
    PAXTON, RJ
    SHIVELY, JE
    TUMOUR BIOLOGY, 1985, 6 (04): : 356 - 356
  • [5] METASTATIC COLORECTAL-CANCER - RADIOIMMUNOSCINTIGRAPHY WITH A STABILIZED IN-111-LABELED F(AB')2 FRAGMENT OF AN ANTI-CEA MONOCLONAL-ANTIBODY
    LAMKI, LM
    PATT, YZ
    ROSENBLUM, MG
    SHANKEN, LJ
    THOMPSON, LB
    SCHWEIGHARDT, SA
    FRINCKE, JM
    MURRAY, JL
    RADIOLOGY, 1990, 174 (01) : 147 - 151
  • [6] RADIOIMMUNOTARGETING IN OVARIAN-CARCINOMA PATIENTS WITH IN-111 LABELED MONOCLONAL-ANTIBODY OV-TL 3 F(AB')2 - PHARMACOKINETICS, TISSUE DISTRIBUTION, AND TUMOR IMAGING
    BUIST, MR
    KENEMANS, P
    VERMORKEN, JB
    GOLDING, RP
    BURGER, CW
    DENHOLLANDERS, W
    VANKAMP, GJ
    VANLINGENS, A
    TEULES, GJJ
    BAAK, JPA
    ROOSS, JC
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1992, 2 (01) : 23 - 34
  • [7] MONOCLONAL-ANTIBODY BW431-26 LABELED WITH TC-99M AND IN-111 - AN INVESTIGATION OF THE BIODISTRIBUTION AND THE DOSIMETRY IN PATIENTS
    BENZ, P
    OBERHAUSEN, E
    BERBERICH, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1991, 18 (10): : 813 - 816
  • [8] RADIOIMMUNODETECTION OF HUMAN-TUMOR XENOGRAFTS BY MONOCLONAL-ANTIBODY F(AB')2 FRAGMENTS
    HERLYN, D
    POWE, J
    MUNZ, DL
    ALAVI, A
    HERLYN, M
    MEINKEN, GE
    SRIVASTAVA, SC
    KOPROWSKI, H
    NUCLEAR MEDICINE AND BIOLOGY, 1986, 13 (04) : 401 - 405
  • [9] THE EFFECT OF TUMOR VIABILITY, ANTIBODY SPECIFICITY AND CHOICE OF DETERMINANT ON IN-111 ANTI-CEA MONOCLONAL-ANTIBODY (MOAB) DISTRIBUTION IN TUMOR-BEARING MICE
    HAGAN, PL
    HALPERN, SE
    BARTHOLOMEW, RM
    FRINCKE, JM
    DAVID, GS
    ADAMS, TH
    JOURNAL OF NUCLEAR MEDICINE, 1983, 24 (05) : P110 - P110
  • [10] IMPROVED IMMUNOSCINTIGRAPHY BY SUBCUTANEOUS INJECTION OF TC-99M OR IN-111 LABELED F(AB')2 FRAGMENTS OF AN ANTIMELANOMA MONOCLONAL-ANTIBODY
    PAGANELLI, G
    RIVA, P
    MOSCATELLI, G
    STACCHIOTTI, A
    AGOSTINI, M
    LANDI, G
    TISON, V
    PANCEA, P
    SICCARDI, AG
    NUCLEAR MEDICINE AND BIOLOGY, 1986, 13 (04): : 423 - &
12345